#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA5124927	Functional	Antiviral activity against HCMV AD-169 infected in HFF cells assessed as reduction in viral replication measured after 14 days	Human betaherpesvirus 5	7	ALA5120909	organism-based format	Scientific Literature
2.	ALA5124928	Toxicity	Cytotoxicity against human HFF cells infected with HCMV AD-169 virus assessed as reduction in cell viability by cell titer-glo assay	Homo sapiens	7	ALA5120909	cell-based format	Scientific Literature
3.	ALA5124929	Toxicity	Selectivity index, ratio of CC50 for cytotoxicity against human HFF cells infected with HCMV AD-169 virus assessed as reduction in cell viability by cell titer-glo assay to EC50 for antiviral activity against HCMV AD-169 infected in HFF cells assessed as inhibition of virus-induced cytopathic effect measured after 14 days		7	ALA5120909	cell-based format	Scientific Literature
4.	ALA5124930	Functional	Antiviral activity against VZV Ellen infected in HFF cells assessed as reduction in viral replication measured after 14 days	Human alphaherpesvirus 3	7	ALA5120909	organism-based format	Scientific Literature
5.	ALA5124931	Toxicity	Cytotoxicity against human HFF cells infected with VZV Ellen virus assessed as reduction in cell viability by cell titer-glo assay	Homo sapiens	7	ALA5120909	cell-based format	Scientific Literature
6.	ALA5124932	Toxicity	Selectivity index, ratio of CC50 for cytotoxicity against human HFF cells infected with VZV Ellen virus assessed as reduction in cell viability by cell titer-glo assay to EC50 for antiviral activity against VZV Ellen infected in HFF cells assessed as inhibition of virus-induced cytopathic effect measured after 14 days		7	ALA5120909	cell-based format	Scientific Literature
7.	ALA5124933	Functional	Anti-HIV activity against wild type HIV-1 IIIB infected in human MT4 cells assessed as inhibition of HIV-induced cytopathic effect measured after 5 days by MTT assay	Human immunodeficiency virus 1	11	ALA5120909	organism-based format	Scientific Literature
8.	ALA5124934	Functional	Anti-HIV activity against wild type HIV-2 ROD infected in human MT4 cells assessed as inhibition of HIV-induced cytopathic effect measured after 5 days by MTT assay	Human immunodeficiency virus 2	11	ALA5120909	organism-based format	Scientific Literature
9.	ALA5124935	Toxicity	Cytotoxicity against human MT4 cells assessed as reduction in cell viability by MTT assay	Homo sapiens	11	ALA5120909	cell-based format	Scientific Literature
10.	ALA5124936	Toxicity	Selectivity index, ratio of CC50 for cytotoxicity against human MT4 cells assessed as reduction in cell viability by MTT assay to EC50 for anti-HIV activity against wild type HIV-1 IIIB infected in human MT4 cells assessed as inhibition of HIV-induced cytopathic effect measured after 5 days by MTT assay		11	ALA5120909	cell-based format	Scientific Literature
11.	ALA5124937	Toxicity	Selectivity index, ratio of CC50 for cytotoxicity against human MT4 cells assessed as reduction in cell viability by MTT assay to EC50 for anti-HIV activity against wild type HIV-2 ROD infected in human MT4 cells assessed as inhibition of HIV-induced cytopathic effect measured after 5 days by MTT assay		11	ALA5120909	cell-based format	Scientific Literature
12.	ALA5124938	Functional	Antiviral activity against wild type HBV infected in human HepG2 2.2.15 cells assessed as reduction in viral replication pre incubated for 3 days followed by replacement with fresh compounds for another 3 days prior to pronase treatment by RT-qPCR analysis	Hepatitis B virus	16	ALA5120909	organism-based format	Scientific Literature
13.	ALA5124940	Functional	Cytotoxicity against human HepG2.2.15 cells assessed as reduction in cell viability by neutral red uptake assay	Homo sapiens	6	ALA5120909	cell-based format	Scientific Literature
14.	ALA5124941	Functional	Cytotoxicity against human HepG2.2.15 cells assessed as reduction in cell viability	Homo sapiens	7	ALA5120909	cell-based format	Scientific Literature
15.	ALA5124942	Functional	Antiviral activity against wild type HBV infected in human HepG2 2.2.15 cells assessed as reduction in viral replication by DNA HYB (Vision)/neutral red (Tox) assay	Hepatitis B virus	2	ALA5120909	organism-based format	Scientific Literature
16.	ALA5124943	Functional	Antiviral activity against wild type HBV infected in human HepG2 2.2.15 cells assessed as reduction in viral replication by DNA HYB (RI)/neutral red (Tox) assay	Hepatitis B virus	2	ALA5120909	organism-based format	Scientific Literature
17.	ALA5124944	Toxicity	Selectivity index, ratio of CC50 cytotoxicity against human HepG2.2.15 cells assessed as reduction in cell viability to EC50 for antiviral activity against wild type HBV infected in human HepG2 2.2.15 cells assessed as reduction in viral replication by DNA HYB (Vision)/neutral red (Tox) assay		2	ALA5120909	cell-based format	Scientific Literature
18.	ALA5124945	Toxicity	Selectivity index, ratio of CC50 cytotoxicity against human HepG2.2.15 cells assessed as reduction in cell viability to EC50 for antiviral activity against wild type HBV infected in human HepG2 2.2.15 cells assessed as reduction in viral replication by DNA HYB (RI)/neutral red (Tox) assay		2	ALA5120909	cell-based format	Scientific Literature